US Biopharmaceutical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
BlockBeats News, July 28th, According to a report by businessinsider, Clinical-stage biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) today announced plans to strategically expand into the cryptocurrency and blockchain space.
The company plans to establish a subsidiary named "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to gradually raise and deploy up to $500 million in funds, with the goal of strategically long-term investing in BNB.
Liminatus emphasized that while the company remains fully committed to its core business - advancing cancer treatments and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
You may also like

The migration of settlement rights: B18 and the institutional starting point of on-chain banks

From Tencent and Circle: Looking at the Simple and Difficult Questions of Investment

The second half of stablecoins no longer belongs to the crypto circle

Cursor "Shell" Kimi Controversy Reversed: From Copyright Infringement Allegations to Authorized Collaboration, China's Open Source Model Once Again Becomes a Global AI Foundation

The Real Reason Tokens Don't Sell: 90% of Crypto Projects Overlook Investor Relations

Is the income of pump.fun real, earning a million dollars a day despite the market downturn?

The real reason why tokens are not selling: 90% of crypto projects neglect investor relations

Who is the true winner of the "Tokenization" narrative?

Moss: The Era of AI-Traded by Anyone | Project Introduction

Chip Smuggling Case Exposes Regulatory Loophole | Rewire News Evening Update

How a Structured AI Crypto Trading Bot Won at the WEEX Hackathon
Ritmex demonstrates how disciplined risk control and structured signals can make an AI crypto trading bot more stable and reliable on WEEX, highlighting the importance of combining execution discipline with scalable AI trading systems.

Old Indicator Fails, Three Major New Signals Emerge: BTC True Bottom May Still Be Below $60K

Meeting OpenClaw Founder at a Hackathon: What Else Can Lobsters Do?

Huang Renxun's Latest Podcast Transcript: NVIDIA's Future, Embodied Intelligence and Agent Development, Soaring Demand for Inferencing, and AI's PR Crisis
How a Structured AI Crypto Trading Bot Won at the WEEX Hackathon
Crypto_Trade shows how structured inputs and controlled adaptability can build a more stable and reliable AI crypto trading bot within the WEEX AI Trading Hackathon, highlighting a practical path toward scalable AI trading systems.

AI Starts to Devour the Manufacturing Industry | Rewire News Morning Edition

When Scaling Meets Speed, Ethereum Foundation Introduces "Hardness" to Safeguard the Base Layer
